Doctor profile · Federal record
Dr. David Bryson, M.D.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Visalia, CA
- NPI 1346248077
- Accepts Medicare
- MIPS 0.0 / 100 · 2023
- 46 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
5345 W Hillsdale Dr.
Visalia, CA 932915143
(559) 622-0100
fax (559) 622-0700
Credentials & registration
- NPI registered
- July 2005 — 21 yrs on file
- Profile last updated
- September 8, 2019
- Year of graduation
- 1980 — 46 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- California #G71842
- Medicaid
- CA #00G718420
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1346248077. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
82,969
Distinct HCPCS
10
Medicare allowed
$938,458
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1453 |
Injection, fosaprepitant, 1 mg | 21,600 | 15 | $0 | |
J1439 |
Injection, ferric carboxymaltose, 1 mg | 15,000 | 11 | $1 | |
J0897 |
Injection, denosumab, 1 mg | 13,560 | 32 | $23 | |
Q5107 |
Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | 7,979 | 13 | $29 | |
J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units | 5,940 | 15 | $7 | |
Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 5,380 | 18 | $8 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 3,280 | 32 | $1 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 3,030 | 39 | $0 | |
J7050 |
Infusion, normal saline solution, 250 cc | 1,156 | 66 | $1 | |
36415 |
Insertion of needle into vein for collection of blood sample | 1,070 | 263 | $8 |
In context: peer comparison
Among 1 peers in Visalia Hematology & Oncology Physician, average services per provider: 2,592. This provider delivers 32× the peer median.Open Payments
Industry payments received
All-time total
$7,122
Transactions
227
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 35 | $1,510.71 | |
| AstraZeneca Pharmaceuticals Lp | 29 | $702.11 | |
| Janssen Biotech, INC. | 18 | $368.06 | |
| Merck Sharp & Dohme LLC | 12 | $315.80 | |
| Genentech USA, INC. | 13 | $315.54 | |
| Exelixis INC. | 14 | $304.25 | |
| Sobi, INC | 15 | $294.40 | |
| Pfizer INC. | 18 | $286.79 | |
| Celgene Corporation | 13 | $235.98 | |
| Daiichi Sankyo INC. | 20 | $234.63 | |
| Eisai INC. | 11 | $193.45 | |
| Gilead Sciences, INC. | 13 | $188.08 | |
| Genzyme Corporation | 6 | $164.72 | |
| GlaxoSmithKline, LLC. | 7 | $148.20 | |
| Aveo Pharmaceuticals, INC. | 3 | $146.23 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,242
Patients
258
Total drug cost
$926,223
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 347 | 81 | $13,499 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 145 | 20 | $8,082 |
| Omeprazole | Generic | 87 | 17 | $2,346 |
| Ondansetron Odt (Ondansetron) | Brand | 85 | 26 | $2,099 |
| Alendronate Sodium | Generic | 81 | 18 | $1,110 |
| Alprazolam | Generic | 81 | 13 | $887 |
| Olanzapine | Generic | 58 | 16 | $3,965 |
| Acyclovir | Generic | 57 | 15 | $1,674 |
| Gabapentin | Generic | 53 | 16 | $1,194 |
| Revlimid (Lenalidomide) | Brand | 47 | 0 | $862,535 |
Frequently asked questions
What is Dr. David Bryson's medical specialty?
Dr. David Bryson practices Hematology & Oncology Physician in Visalia, CA.
Where does Dr. David Bryson practice?
Dr. David Bryson practices at 5345 W Hillsdale Dr., Visalia, CA 932915143. Office phone: 5596220100.
What is Dr. David Bryson's NPI?
Dr. David Bryson's National Provider Identifier (NPI) is 1346248077, issued by NPPES.
Does Dr. David Bryson accept Medicare assignment?
Yes. Dr. David Bryson accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. David Bryson commonly perform?
Top Medicare-reported procedures in 2023: Injection, fosaprepitant, 1 mg (HCPCS J1453); Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.